Annual EPS
-$989.44
+$1665.28+62.73%
31 December 2023
Summary:
Seelos Therapeutics annual earnings per share is currently -$989.44, with the most recent change of +$1665.28 (+62.73%) on 31 December 2023. During the last 3 years, it has risen by +$661.76 (+40.08%). SEEL annual EPS is now -140.69% below its all-time high of $2431.82, reached on 31 December 2017.SEEL EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EPS
$1.92
+$27.52+107.50%
30 June 2024
Summary:
Seelos Therapeutics quarterly earnings per share is currently $1.92, with the most recent change of +$27.52 (+107.50%) on 30 June 2024. Over the past year, it has increased by +$462.72 (+100.42%). SEEL quarterly EPS is now -100.00% below its all-time high of $284.95 thousand, reached on 31 December 2008.SEEL Quarterly EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EPS
-$475.52
+$860.48+64.41%
30 June 2024
Summary:
Seelos Therapeutics TTM earnings per share is currently -$475.52, with the most recent change of +$860.48 (+64.41%) on 30 June 2024. Over the past year, it has increased by +$1960.00 (+80.48%). SEEL TTM EPS is now -100.57% below its all-time high of $83.36 thousand, reached on 30 June 2017.SEEL TTM EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SEEL EPS Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +62.7% | +100.4% | +80.5% |
| 3 y3 years | +40.1% | +100.5% | +80.0% |
| 5 y5 years | +97.4% | +100.4% | +98.9% |
SEEL EPS High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +64.7% | -78.6% | +100.2% | at high | +84.3% |
| 5 y | 5 years | at high | +97.4% | -78.6% | +100.1% | at high | +98.9% |
| alltime | all time | -140.7% | +100.0% | -100.0% | +100.0% | -100.6% | +100.0% |
Seelos Therapeutics EPS History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2024 | - | $1.92(-107.5%) | -$475.52(-64.4%) |
| Mar 2024 | - | -$25.60(-385.7%) | -$1336.00(-24.5%) |
| Dec 2023 | -$989.44(-62.7%) | $8.96(-101.9%) | -$1768.64(-27.4%) |
| Sept 2023 | - | -$460.80(-46.3%) | -$2435.52(-8.6%) |
| June 2023 | - | -$858.56(+87.4%) | -$2665.92(+3.5%) |
| Mar 2023 | - | -$458.24(-30.4%) | -$2575.36(-1.6%) |
| Dec 2022 | -$2654.72(-5.3%) | -$657.92(-4.8%) | -$2616.32(-13.8%) |
| Sept 2022 | - | -$691.20(-10.0%) | -$3033.60(+9.7%) |
| June 2022 | - | -$768.00(+53.8%) | -$2764.80(+16.1%) |
| Mar 2022 | - | -$499.20(-53.6%) | -$2380.80(-19.5%) |
| Dec 2021 | -$2803.20(+69.8%) | -$1075.20(+154.5%) | -$2956.80(+24.2%) |
| Sept 2021 | - | -$422.40(+10.0%) | -$2380.80(+3.3%) |
| June 2021 | - | -$384.00(-64.3%) | -$2304.00(+3.4%) |
| Mar 2021 | - | -$1075.20(+115.4%) | -$2227.20(+31.8%) |
| Dec 2020 | -$1651.20(-82.9%) | -$499.20(+44.4%) | -$1689.60(-37.5%) |
| Sept 2020 | - | -$345.60(+12.5%) | -$2704.89(-5.4%) |
| June 2020 | - | -$307.20(-42.9%) | -$2858.49(-1.3%) |
| Mar 2020 | - | -$537.60(-64.5%) | -$2896.89(-83.6%) |
| Dec 2019 | -$9676.80(-74.3%) | -$1514.49(+203.4%) | -$17.64 K(-60.5%) |
| Sept 2019 | - | -$499.20(+44.4%) | -$44.65 K(-8.2%) |
| June 2019 | - | -$345.60(-97.7%) | -$48.64 K(-18.3%) |
| Mar 2019 | - | -$15.28 K(-46.4%) | -$59.51 K(-1.4%) |
| Dec 2018 | -$37.72 K(-1651.2%) | -$28.52 K(+534.3%) | -$60.34 K(+19.8%) |
| Sept 2018 | - | -$4495.90(-59.9%) | -$50.35 K(-33.2%) |
| June 2018 | - | -$11.22 K(-30.4%) | -$75.33 K(-2.8%) |
| Mar 2018 | - | -$16.11 K(-13.1%) | -$77.51 K(-231.2%) |
| Dec 2017 | $2431.82(-102.2%) | -$18.53 K(-37.1%) | $59.09 K(-19.2%) |
| Sept 2017 | - | -$29.48 K(+120.0%) | $73.15 K(-12.2%) |
| June 2017 | - | -$13.40 K(-111.1%) | $83.36 K(+146.8%) |
| Mar 2017 | - | $120.49 K(-2800.0%) | $33.78 K(-125.2%) |
| Dec 2016 | -$110.94 K(-74.9%) | -$4462.69(-76.8%) | -$133.98 K(-27.1%) |
| Sept 2016 | - | -$19.27 K(-69.4%) | -$183.75 K(-34.7%) |
| June 2016 | - | -$62.98 K(+33.3%) | -$281.55 K(-17.3%) |
| Mar 2016 | - | -$47.26 K(-12.8%) | -$340.54 K(-23.0%) |
| Dec 2015 | -$442.40 K(-22.8%) | -$54.23 K(-53.7%) | -$442.40 K(-47.9%) |
| Sept 2015 | - | -$117.07 K(-4.0%) | -$848.97 K(+3.0%) |
| June 2015 | - | -$121.98 K(-18.2%) | -$824.06 K(+27.7%) |
| Mar 2015 | - | -$149.12 K(-67.6%) | -$645.20 K(+7.9%) |
| Dec 2014 | -$573.32 K(+8.3%) | -$460.80 K(+400.0%) | -$598.02 K(+233.6%) |
| Sept 2014 | - | -$92.16 K(-262.0%) | -$179.25 K(-0.6%) |
| June 2014 | - | $56.88 K(-155.8%) | -$180.37 K(-49.9%) |
| Mar 2014 | - | -$101.94 K(+142.5%) | -$360.22 K(-39.1%) |
| Dec 2013 | -$529.31 K(-58.3%) | -$42.03 K(-54.9%) | -$591.86 K(-55.7%) |
| Sept 2013 | - | -$93.28 K(-24.1%) | -$1.34 M(-0.5%) |
| June 2013 | - | -$122.97 K(-63.1%) | -$1.34 M(-6.4%) |
| Mar 2013 | - | -$333.58 K(-57.5%) | -$1.43 M(+9.9%) |
| Dec 2012 | -$1.27 M(+26.3%) | -$785.48 K(+687.4%) | -$1.30 M(+67.3%) |
| Sept 2012 | - | -$99.76 K(-53.4%) | -$779.48 K(-3.8%) |
| June 2012 | - | -$214.17 K(+4.5%) | -$810.34 K(-23.2%) |
| Mar 2012 | - | -$204.91 K(-21.4%) | -$1.05 M(+0.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2011 | -$1.01 M(-45.4%) | -$260.64 K(+99.5%) | -$1.05 M(-35.4%) |
| Sept 2011 | - | -$130.61 K(-71.5%) | -$1.63 M(-6.1%) |
| June 2011 | - | -$458.48 K(+128.5%) | -$1.73 M(+1.8%) |
| Mar 2011 | - | -$200.65 K(-76.0%) | -$1.70 M(-39.7%) |
| Dec 2010 | -$1.84 M(-65.5%) | -$836.60 K(+253.1%) | -$2.82 M(-59.7%) |
| Sept 2010 | - | -$236.93 K(-44.6%) | -$7.00 M(-0.0%) |
| June 2010 | - | -$427.86 K(-67.6%) | -$7.00 M(+2.1%) |
| Mar 2010 | - | -$1.32 M(-73.7%) | -$6.86 M(+27.8%) |
| Dec 2009 | -$5.34 M(+313.1%) | -$5.02 M(+2007.5%) | -$5.37 M(+7890.7%) |
| Sept 2009 | - | -$238.12 K(-16.5%) | -$67.21 K(-88.6%) |
| June 2009 | - | -$285.23 K(-266.6%) | -$589.11 K(-17.2%) |
| Mar 2009 | - | $171.19 K(-39.9%) | -$711.06 K(-45.0%) |
| Dec 2008 | -$1.29 M(-41.2%) | $284.95 K(-137.5%) | -$1.29 M(-42.6%) |
| Sept 2008 | - | -$760.02 K(+86.7%) | -$2.25 M(+12.2%) |
| June 2008 | - | -$407.18 K(-0.8%) | -$2.01 M(-4.3%) |
| Mar 2008 | - | -$410.55 K(-39.1%) | -$2.10 M(-4.5%) |
| Dec 2007 | -$2.20 M(+8.4%) | -$673.63 K(+30.7%) | -$2.20 M(+6.9%) |
| Sept 2007 | - | -$515.59 K(+3.6%) | -$2.05 M(-6.7%) |
| June 2007 | - | -$497.76 K(-2.4%) | -$2.20 M(+7.5%) |
| Mar 2007 | - | -$509.83 K(-4.1%) | -$2.05 M(-18.9%) |
| Dec 2006 | -$2.03 M(-63.3%) | -$531.57 K(-19.8%) | -$2.53 M(-18.7%) |
| Sept 2006 | - | -$662.61 K(+92.4%) | -$3.11 M(-13.9%) |
| June 2006 | - | -$344.45 K(-65.1%) | -$3.61 M(-37.9%) |
| Mar 2006 | - | -$986.98 K(-11.2%) | -$5.81 M(-18.6%) |
| Dec 2005 | -$5.52 M(-35.2%) | -$1.11 M(-4.5%) | -$7.14 M(-12.6%) |
| Sept 2005 | - | -$1.16 M(-54.3%) | -$8.16 M(-12.8%) |
| June 2005 | - | -$2.55 M(+10.2%) | -$9.36 M(+5.9%) |
| Mar 2005 | - | -$2.31 M(+8.1%) | -$8.83 M(+3.8%) |
| Dec 2004 | -$8.51 M(-16.4%) | -$2.14 M(-9.3%) | -$8.51 M(-23.7%) |
| Sept 2004 | - | -$2.36 M(+16.5%) | -$11.16 M(+7.1%) |
| June 2004 | - | -$2.02 M(+1.7%) | -$10.42 M(-16.6%) |
| Mar 2004 | - | -$1.99 M(-58.4%) | -$12.49 M(-10.5%) |
| Dec 2003 | -$10.18 M(-63.2%) | -$4.79 M(+195.8%) | -$13.95 M(-19.9%) |
| Sept 2003 | - | -$1.62 M(-60.5%) | -$17.41 M(-23.2%) |
| June 2003 | - | -$4.10 M(+18.7%) | -$22.67 M(-11.2%) |
| Mar 2003 | - | -$3.45 M(-58.1%) | -$25.51 M(-7.7%) |
| Dec 2002 | -$27.64 M(+70.9%) | -$8.25 M(+19.9%) | -$27.64 M(+9.2%) |
| Sept 2002 | - | -$6.88 M(-0.9%) | -$25.31 M(+15.6%) |
| June 2002 | - | -$6.94 M(+24.4%) | -$21.89 M(+18.1%) |
| Mar 2002 | - | -$5.58 M(-5.7%) | -$18.54 M(+14.6%) |
| Dec 2001 | -$16.17 M(+83.2%) | -$5.92 M(+71.1%) | -$16.17 M(+19.5%) |
| Sept 2001 | - | -$3.46 M(-3.7%) | -$13.54 M(+13.5%) |
| June 2001 | - | -$3.59 M(+11.7%) | -$11.92 M(+10.4%) |
| Mar 2001 | - | -$3.21 M(-2.0%) | -$10.80 M(+22.4%) |
| Dec 2000 | -$8.83 M(+252.2%) | -$3.28 M(+78.0%) | -$8.83 M(+59.1%) |
| Sept 2000 | - | -$1.84 M(-25.4%) | -$5.55 M(+49.7%) |
| June 2000 | - | -$2.47 M(+99.4%) | -$3.71 M(+199.4%) |
| Mar 2000 | - | -$1.24 M | -$1.24 M |
| Dec 1999 | -$2.51 M(-77.3%) | - | - |
| Dec 1998 | -$11.06 M(+186.7%) | - | - |
| Dec 1997 | -$3.86 M | - | - |
FAQ
- What is Seelos Therapeutics annual earnings per share?
- What is the all time high annual EPS for Seelos Therapeutics?
- What is Seelos Therapeutics annual EPS year-on-year change?
- What is Seelos Therapeutics quarterly earnings per share?
- What is the all time high quarterly EPS for Seelos Therapeutics?
- What is Seelos Therapeutics quarterly EPS year-on-year change?
- What is Seelos Therapeutics TTM earnings per share?
- What is the all time high TTM EPS for Seelos Therapeutics?
- What is Seelos Therapeutics TTM EPS year-on-year change?
What is Seelos Therapeutics annual earnings per share?
The current annual EPS of SEEL is -$989.44
What is the all time high annual EPS for Seelos Therapeutics?
Seelos Therapeutics all-time high annual earnings per share is $2431.82
What is Seelos Therapeutics annual EPS year-on-year change?
Over the past year, SEEL annual earnings per share has changed by +$1665.28 (+62.73%)
What is Seelos Therapeutics quarterly earnings per share?
The current quarterly EPS of SEEL is $1.92
What is the all time high quarterly EPS for Seelos Therapeutics?
Seelos Therapeutics all-time high quarterly earnings per share is $284.95 K
What is Seelos Therapeutics quarterly EPS year-on-year change?
Over the past year, SEEL quarterly earnings per share has changed by +$462.72 (+100.42%)
What is Seelos Therapeutics TTM earnings per share?
The current TTM EPS of SEEL is -$475.52
What is the all time high TTM EPS for Seelos Therapeutics?
Seelos Therapeutics all-time high TTM earnings per share is $83.36 K
What is Seelos Therapeutics TTM EPS year-on-year change?
Over the past year, SEEL TTM earnings per share has changed by +$1960.00 (+80.48%)